Biotech Bros

By Biotech Bros LLC.

Discussing the world of biotech!... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Biotech Bros:

How many episodes does Biotech Bros have?

The podcast currently has 93 episodes available.

Biotech Bros episodes:

February 06, 2023 Ensysce Biosciences: A Solution to the Opioid Crisis?
This week on the podcast Agustin sits down with the Lynn Kirkpatrick the CEO of Ensysce Biosciences. Ensysce is an innovative company that is seeking to address the opioid crisis by leveraging advanced chemistry to prevent opioid abuse and ensure targeted and appropriate dosing of pain medications. Apart from opioids, Ensysce is looking to leverage their technology across a host of indications with the goal of making drug delivery safer and more effective.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
26min
January 24, 2023 CRL for Eli Lilly and Leap Therapeutics Searches for a Flame?
This week on the podcast Agustin discusses some new developments in the Alzheimer's space with the FDA's recent CRL for Eli Lilly's beta amyloid antibody. He also shares his thoughts on Leap Therapeutics' acquisition of Flame Biosciences and what it means for future commercialization strategies
All Business. No Boundaries.
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
53min
January 16, 2023 A Lackluster JPM and a Troubling future for Fate Therapeutics
This week on the podcast Agustin discusses the excitement for 2023 in biotech investing and highlights some key tailwinds that could provide a return to positive returns for investors. He also discusses the rather lackluster JPM conference and highlights the troubles plaguing Fate Therapeutics and other natural killer cell therapy companies.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
57min
January 02, 2023 A Therapy for NASH, Another Alzheimer's Competitor, and Reflections on 2022
This week on the podcast Agustin discusses Madrigal Pharmaceuticals' recent phase III win in NASH, he highlights another monoclonal antibody in the Alzheimer's space, and provides a reflection on the markets in 2022.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
1h 3min
December 12, 2022 Questions around the Tesla of Biotech, Amgen buying Horizon, and Mirati in the Dumps
This week on the podcast Agustin shares some recent action and news in the biotech market from failed acquisitions to a pending purchase to questions around a synthetic biology powerhouse.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
1h 1min
November 21, 2022 Setting the Record Straight with $LPTX and $AFMD
This week on the podcast Agustin provides updates on key readouts from Affimed and Leap Therapeutics in particular setting the record straight for their recent data readouts. In addition he shares some exciting news regarding a new initiative!
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
1h 5min
November 07, 2022 PRIME Medicines Big IPO and an attractive play in the NASH space
This week on the podcast Agustin talks about the recent fluctuations within the market, the 300 million dollar IPO of a big time base editing gene therapy company, and highlights an interesting play within the NASH space.
All Business. No Boundaries.
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
57min
October 17, 2022 Behind the Scenes of an IPO: Interview with TC Biopharm
This week on the podcast Agustin sits down with the Bryan Kobel CEO of TC Biopharm. Bryan spent years leading healthcare investment banking at EF Hutton and the Alberleen Group before switching roles and joining TC Biopharm.

On this podcast we discuss a host of topics from TC Biopharm's IPO earlier in the year, to the state of biotech and equity markets, to the transformative technology behind TC Biopharm.
All Business. No Boundaries.
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
54min
October 11, 2022 A Potential Recession and Another Alzheimer's Drug from Biogen
This week on the podcast Agustin talks recent macroeconomic trends and their implications on the stock market and biotech specifically, highlights the positive phase 3 data for another Biogen Alzheimer's drug, and shares the recent approval for Amylyx Pharmaceuticals and their 6-figure a year drug for ALS.
All Business. No Boundaries.
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
53min
September 12, 2022 Good News for $AMLX and Covid Booster Approvals with only Mouse Data?
This week on the podcast Agustin discusses news around Amgen's big 1L data drop for its KRAS inhibitor Lumakras, the shifting perceptions for $AMLX and what could become an approval for their ALS therapy, and the shortsightedness of the FDA and CDC around approving covid boosters based only on mouse data!

If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
All Business. No Boundaries.
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
...more
53min

FAQs about Biotech Bros:

How many episodes does Biotech Bros have?

The podcast currently has 93 episodes available.